A new drug is offering new hope for women with advanced stage of breast cancer. The drug called 'Capivasetib' has been approved for NHS funding in England. Now this targeted therapy has shown remarkable results in slowing down cancer progression and shrinking tumors in a quarter of patients. Watch in for more details!